Elmore, SA, et al.
Toxoplasma gondii: epidemiology, feline clinical aspects, and prevention. Trends in Parasitology
2010; 26: 190–196.
Elsheikha, HM. Congenital toxoplasmosis: priorities for further health promotion action. Public Health
2008; 122: 335–353.
Ong, E. Common AIDS-associated opportunistic infections. Clinical Medicine
2008; 8: 539–543.
Weiss, LM, Dubey, JP. Toxoplasmosis: a history of clinical observations. International Journal for Parasitology
2009; 39: 895–901.
Tenter, AM, et al.
Toxoplasma gondii: from animals to humans. International Journal for Parasitology
2000; 30: 1217–1258.
Dawson, D. Foodborne protozoan parasites. International Journal of Food Microbiology
2005; 103: 207–227.
Jones, JL, Dubey, JP. Foodborne toxoplasmosis. Clinical Infectious Diseases
2012; 55: 845–851.
Villena, I, et al.
Evaluation of a strategy for Toxoplasma gondii oocyst detection in water. Applied and Environmental Microbiology
2004; 70: 4035–4039.
Patel, R. Disseminated toxoplasmosis after liver transplantation. Clinical Infectious Diseases
1999; 29: 705–706.
Walker, M, et al.
Parasitic central nervous system infections in immunocompromised hosts. Clinical Infectious Diseases
2005; 40: 1005–1015.
Balasundaram, MB, et al.
Outbreak of acquired ocular toxoplasmosis involving 248 patients. Archives of Ophthalmology
2010; 128: 28–32.
Weitberg, AB, et al.
Acute granulomatous hepatitis in the course of acquired toxoplasmosis. New England Journal of Medicine
1979; 300: 1093–1096.
Karasawa, T, et al.
Localized hepatic necrosis related to cytomegalovirus and Toxoplasma gondii
. Acta Pathologica Japonica
1981; 31: 527–534.
Tiwari, I, et al.
Cholestatic jaundice due to toxoplasma hepatitis. Postgraduate Medical Journal
1982; 58: 299–300.
Hassan, MM, et al.
Parasitic causes of hepatomegaly in children. Journal of the Egyptian Society of Parasitology
1996; 26: 177–189.
Ustun, S, et al.
Incidence of toxoplasmosis in patients with cirrhosis. World Journal of Gastroenterology
2004; 10: 452–454.
Doğan, N, et al.
Toxoplasmic hepatitis in an immunocompetent patient. Türkiye Parazitoloji Dergisi
2007; 31: 260–263.
Shapira, Y, et al.
Serum markers of infections in patients with primary biliary cirrhosis: evidence of infection burden. Experimental and Molecular Pathology
2012; 93: 386–390.
Ortego, TJ, et al.
Toxoplasmic chorioretinitis and hepatic granulomas. American Journal of Gastroenterology
1990; 85: 1418–1420.
Wendum, D, et al.
Fatal disseminated toxoplasmosis in a toxoplasma seropositive liver transplant recipient. Journal of Clinical Pathology
2002; 55: 637.
Mordue, DG, et al.
Acute toxoplasmosis leads to lethal overproduction of Th1 cytokines. Journal of Immunology
2001; 167: 4574–4584.
Atmaca, HT, et al.
Hepatic stellate cells increase in Toxoplasma gondii infection in mice. Parasites and Vectors
2013; 6: 135.
He, JJ, et al.
Transcriptomic analysis of mouse liver reveals a potential hepato-enteric pathogenic mechanism in acute Toxoplasma gondii infection. Parasites and Vectors
2016; 9: 427.
He, JJ, et al.
Proteomic profiling of mouse liver following acute Toxoplasma gondii infection. PLoS ONE
2016; 11: e0152022.
El-Sayed, NM, et al.
Toxoplasma gondii infection and chronic liver diseases: evidence of an association. Tropical Medicine and Infectious Diseases
2016; 1: 7.
Alvarado-Esquivel, C, et al.
Toxoplasma gondii infection and liver disease: a case-control study in a northern Mexican population. Parasites and Vectors
2011; 4: 75.
Montoya, JG, Liesenfeld, O. Toxoplasmosis. Lancet
2004; 363: 1965–1976.
Mokdad, AA, et al.
Liver cirrhosis mortality in 187 countries between 1980 and 2010: a systematic analysis. BMC Medicine
2014; 12: 145.
Bonacini, M, et al.
Duodenal and hepatic toxoplasmosis in a patient with HIV infection: review of the literature. American Journal of Gastroenterology
1996; 91: 1838–1840.
Mastroianni, A, et al.
Liver toxoplasmosis and acquired immunodeficiency syndrome. Recenti Progressi in Medicina
1996; 87: 353–355.
Ghanam, ME, et al.
Evaluation of the role of some parasitic infections as a cause of acute and chronic hepatic diseases.
Journal of the Egyptian Society of Parasitology
2001; 31: 37–42.
El-Nahas, HA, et al.
Toxoplasma gondii infection among chronic hepatitis C patients: a case-control study. Asian Pacific Journal of Tropical Medicine
2014; 7: 589–593.
Da Silva, AS, et al.
Relationship between butyrylcholinesterase activity and liver injury in mice acute infected with Toxoplasma gondii
. Pathology, Research and Practice
2013; 209: 95–98.
Cong, W, et al.
Toxoplasma gondii infection in cancer patients: prevalence, risk factors, genotypes and association with clinical diagnosis. Cancer Letters
2015; 359: 307–313.
Yazar, S, et al.
Investigation of anti-Toxoplasma gondii antibodies in patients with neoplasia. Journal of Medical Microbiology
2004; 53: 1183–1186.
Evering, T, Weiss, LM. The immunology of parasite infections in immunocompromised hosts. Parasite Immunology
2006; 28: 549–565.
Du, F, et al.
Survey on the contamination of Toxoplasma gondii oocysts in the soil of public parks of Wuhan, China. Veterinary Parasitology
2012; 184: 141–146.
Jones, JL, et al.
Risk factors for Toxoplasma gondii infection in the United States. Clinical Infectious Diseases
2009; 49: 878–884.
Torrey, EF, Yolken, RH.
Toxoplasma oocysts as a public health problem. Trends in Parasitology
2013; 29: 380–384.
Jones, JL, Dubey, JP. Waterborne toxoplasmosis – recent developments. Experimental Parasitology
2010; 124: 10–25.
Elsheikha, HM, et al.
Seroprevalence of and risk factors for Toxoplasma gondii antibodies among asymptomatic blood donors in Egypt. Parasitology Research
2009; 104: 1471–1476.
Wilking, H, et al.
Prevalence, incidence estimations, and risk factors of Toxoplasma gondii infection in Germany: a representative, cross-sectional, serological study. Scientific Reports
2016; 6: 22551.